HomeInsightsStock Comparison

Divis Laboratories Ltd vs Neuland Laboratories Ltd Stock Comparison

Divis Laboratories Ltd vs Neuland Laboratories Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Divis Laboratories Ltd is ₹ 6801 as of 16 Jul 12:48.
  • The P/E Ratio of Divis Laboratories Ltd changed from 38.3 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Neuland Laboratories Ltd changed from 22.5 on March 2020 to 59.9 on March 2025 . This represents a CAGR of 17.73% over 6 years.
  • The Market Cap of Divis Laboratories Ltd changed from ₹ 52763 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Neuland Laboratories Ltd changed from ₹ 363.66 crore on March 2020 to ₹ 15494 crore on March 2025 . This represents a CAGR of 86.89% over 6 years.
  • The revenue of Divis Laboratories Ltd for the Mar '25 is ₹ 2671 crore as compare to the Dec '24 revenue of ₹ 2401 crore. This represent the growth of 11.25% The revenue of Neuland Laboratories Ltd for the Mar '25 is ₹ 335.82 crore as compare to the Dec '24 revenue of ₹ 457.72 crore. This represent the decline of -26.63%.
  • The ebitda of Divis Laboratories Ltd for the Mar '25 is ₹ 971 crore as compare to the Dec '24 ebitda of ₹ 825 crore. This represent the growth of 17.7% The ebitda of Neuland Laboratories Ltd for the Mar '25 is ₹ 58.54 crore as compare to the Dec '24 ebitda of ₹ 146.28 crore. This represent the decline of -59.98%.
  • The net profit of Divis Laboratories Ltd changed from ₹ 356 crore to ₹ 662 crore over 8 quarters. This represents a CAGR of 36.37% The net profit of Neuland Laboratories Ltd changed from ₹ 61.88 crore to ₹ 27.81 crore over 8 quarters. This represents a CAGR of -32.96% .
  • The Dividend Payout of Divis Laboratories Ltd changed from 33.04 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Neuland Laboratories Ltd changed from 16.25 % on March 2020 to 5.97 % on March 2025 . This represents a CAGR of -15.37% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Divis Laboratories Ltd

  • Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
  • The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
  • It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
  • In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
  • It is among the largest pharmaceutical companies in India with a portfolio of approx.

About Neuland Laboratories Ltd

  • Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao.
  • The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin.
  • Neuland Drugs & Pharmaceuticals Pvt.
  • Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992.
  • NLL manufactures bulk drugs. The Company came out with its initial public offering in Apr.'94 at a premium of Rs 35 aggregating Rs 5.69 cr, to part-finance the capacity expansion to manufacture bulk drugs and to diversify its product-mix.

Divis Laboratories Ltd News Hub

News

Divis Laboratories Ltd up for third consecutive session

Divis Laboratories Ltd is up for a third straight session today. The stock is quoting at R...

Read more

11 Jun 2025 13:05

News

Divis Laboratories Ltd down for fifth straight session

Divis Laboratories Ltd is down for a fifth straight session today. The stock is quoting at...

Read more

02 Jun 2025 13:35

News

Divis Lab inks long-term global pharma deal

As part of the agreement, Divis will manufacture and supply advanced pharmaceutical interm...

Read more

24 May 2025 10:06

News

Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.

Divis Laboratories has entered into a long term manufacturing and supply agreement with a ...

Read more

24 May 2025 11:34

News

Divis Lab gains after Q4 PAT climbs 23% YoY; recommends final dividend of Rs 30/ share

Revenue from operations grew by 12.24% year on year (YoY) to Rs 2,585 crore in the quarter...

Read more

19 May 2025 10:00

News

Divis Laboratories to convene AGM

Divis Laboratories announced that the 35th Annual General Meeting(AGM) of the company will...

Read more

19 May 2025 17:49

Neuland Laboratories Ltd News Hub

News

Neuland Laboratories to hold board meeting

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 31 Ju...

Read more

15 Jul 2025 09:52

News

Neuland Laboratories Ltd leads gainers in 'A' group

Anand Rathi Wealth Ltd, Piramal Enterprises Ltd, Vodafone Idea Ltd and Tega Industries Ltd...

Read more

14 Jul 2025 12:00

News

Volumes soar at Neuland Laboratories Ltd counter

Ola Electric Mobility Ltd, Anand Rathi Wealth Ltd, Castrol India Ltd, Piramal Enterprises ...

Read more

14 Jul 2025 14:30

News

Volumes spurt at Neuland Laboratories Ltd counter

Petronet LNG Ltd, Sterling & Wilson Renewable Energy Ltd, Dr Lal Pathlabs Ltd, HFCL Ltd ar...

Read more

09 Jul 2025 11:00

News

Neuland Laboratories to hold AGM

Neuland Laboratories announced that the 41th Annual General Meeting(AGM) of the company wi...

Read more

17 May 2025 12:57

News

Neuland Labs drops after Q4 PAT slumps 59% YoY to Rs 28 cr

On quarter on quarter (QoQ) basis, the company's net profit declined 72.63% while revenue ...

Read more

16 May 2025 14:51

SWOT Analysis Of Divis Laboratories Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Neuland Laboratories Ltd

Strength

5

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Divis Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Neuland Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Divis Laboratories Ltd and Neuland Laboratories Ltd

Which company has a larger market capitalization, Divis Laboratories Ltd or Neuland Laboratories Ltd?

Market cap of Divis Laboratories Ltd is 180,214 Cr while Market cap of Neuland Laboratories Ltd is 19,628 Cr

What are the key factors driving the stock performance of Divis Laboratories Ltd and Neuland Laboratories Ltd?

The stock performance of Divis Laboratories Ltd and Neuland Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Divis Laboratories Ltd and Neuland Laboratories Ltd?

As of July 16, 2025, the Divis Laboratories Ltd stock price is INR ₹6788.55. On the other hand, Neuland Laboratories Ltd stock price is INR ₹15298.9.

How do dividend payouts of Divis Laboratories Ltd and Neuland Laboratories Ltd compare?

To compare the dividend payouts of Divis Laboratories Ltd and Neuland Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions